Today, Congressman Jodey Arrington (TX-19) announced the introduction of H.Res. 676, which encourages the United States to formally withdraw from the 2016 Paris Climate Agreement. The Agreement, which went into effect on November 4, 2016, did not have congressional approval and resulted in burdensome regulatory measures that put the United States at a competitive disadvantage,… Read more »
Today, Congressman Jodey Arrington (TX-19) spoke on the House floor after the U.S. House of Representatives voted to begin an ‘impeachment inquiry’ against President Donald J. Trump.
“Today was a sad day for our country. We now have round two of this phony impeachment process that’s purely political, not based in fact, and not based in the pursuit of truth and… Read more »
Today, the U.S. House of Representatives voted 403-0 to pass the Public Disclosure of Drug Discounts Act (H.R. 2115) – bipartisan legislation introduced by Congressman Jodey Arrington (TX-19), Congresswoman Abigail Spanberger (VA-7), and Congressman Brendan Boyle (PA-2) to provide greater transparency to the discounts negotiated between insurance companies and drug… Read more »
Writing in The Hill this week, Congressman Jodey Arrington (TX-19) criticized House Democrats’ irresponsible and unprecedented ‘impeachment inquiry,’ through which they are abandoning past precedent, preventing the minority party from cross-examining witnesses, and conducting interviews in secret:
“While Speaker Nancy Pelosi (D-Calif.) is trying to… Read more »
Today, Congressman Jodey Arrington (TX-19) joined “Cavuto: Coast to Coast” on the Fox Business Network to discuss the House Democrat leadership’s continued delay in ratifying the U.S.-Mexico-Canada Agreement (USMCA), even after Mexican President Andrés Manuel López Obrador urged Democrats on the House Ways and Means Committee to move forward in ratifying the… Read more »
Today, Congressman Jodey Arrington (TX-19) spoke out against House Democrats’ big government drug pricing proposal (H.R. 3) during a hearing of the House Ways and Means Committee. The proposal would implement government-controlled pricing of prescription drugs, resulting in less investment in medical research and more than a dozen fewer life-saving prescription drugs coming to… Read more »
Today, Congressman Jodey Arrington issued a final call for qualified candidates in Texas’ 19th Congressional District to apply for Military Academy Nominations ahead of the the October 15th deadline. Congressman Arrington may nominate up to ten individuals from the 19th District to be considered for appointment.
“It is my distinguished honor to nominate… Read more »
Today, Congressman Jodey Arrington (TX-19) released the following statement after the White House announced they would refuse to engage in House Democrats’ baseless impeachment inquiry:
“Speaker Pelosi’s ‘impeachment inquiry’ – in addition to being baseless – is a departure from past precedent and denies the President his… Read more »
Today, Congressman Jodey Arrington (TX-19) released the following statement on President Trump’s executive order to provide more choice, eliminate waste, fraud, and abuse, and lower costs for Medicare beneficiaries in West Texas and across the country:
“While Democrats focus on promoting a complete government takeover of our health care system by putting Washington first, the… Read more »
Today, Congressman Jodey Arrington (TX-19) congratulated the Trump Administration on reaching a trade agreement with Japan that will deliver a major victory to farmers and ranchers in West Texas and across the United States. Specifically, the agreement provides increased market access for American agriculture producers by significantly reducing or completely eliminating tariffs on $7.2… Read more »
